Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

44%

4 trials in Phase 3/4

Results Transparency

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

5(55.6%)

Phase 3

3(33.3%)

Phase 4

1(11.1%)

9Total

N/A(5)

Phase 3(3)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT04543812Phase 3Completed

PBF-1681 (Ferric Citrate) for the Treatment of IDA in Patients With NDD-CKD

Role: lead

NCT06013332Not ApplicableActive Not Recruiting

Polymeric Microspheres vs Sculptra® in the Treatment of Moderate to Severe Nasolabial Folds

Role: collaborator

NCT05781620Not ApplicableUnknown

Vitamin D Supplementation in Healthy Adults in Prolonged Endurance Exercise

Role: collaborator

NCT05779410Not ApplicableCompleted

Vitamin D in Healthy Adults After Strenuous Endurance Exercise

Role: collaborator

NCT05779488Not ApplicableUnknown

Maca in Healthy Subjects After Strenuous Endurance Exercise

Role: collaborator

NCT04583852Not ApplicableCompleted

Evaluate the Efficacy and Safety of Brightening Micro-needle Patch on Facial Solar Lentigines

Role: lead

NCT03984760Phase 3Completed

Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing Hemodialysis

Role: lead

NCT03256838Phase 4Completed

Assess the Safety and Efficacy of Nephoxil® in Subjects With End Stage Renal Disease (ESRD) on Dialysis

Role: lead

NCT01503736Phase 3Completed

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal Disease

Role: lead

All 9 trials loaded